Cardiovascular · 510(k) · 2017

CardioLogs ECG Analysis Platform

Cardiologs Technologies. Cleared by FDA on 26 June 2017 under submission K170568, product code DPS (electrocardiograph). What FDA's record says, in FDA's words.

Device record · K170568

  1. Device. CardioLogs ECG Analysis PlatformDEVICE
  2. Company. Cardiologs Technologies (FR)COMPANY
  3. Decision. 26 June 2017, 510(k), substantially equivalent (traditional review); received 27 February 2017DECISION
  4. Panel. CardiovascularPANEL
  5. Product code. DPS, ElectrocardiographCODE
  6. Regulation. 21 CFR 870.2340, Class IIREG
  7. Source. FDA database entry · decision document (10 pages)SOURCE

Retrieved · the fields above are FDA's; the statement below was copied from the decision document on that day.

What FDA cleared it for

The Indications for Use statement, verbatim, from the decision document.

The CardioLogs ECG Analysis Platform is intended for use by qualified healthcare professionals for the assessment of arrhythmias using ECG data in subjects over 18 years of age. The product supports downloading and analyzing data recorded in compatible formats from any device used for the arrhythmia diagnostics such as Holter, event recorder, 12 lead ambulatory ECG devices, or other similar devices when assessment of the rhythm is necessary. The Cardiologs ECG Analysis Platform can also be electronically interfaced, and perform analysis with data transferred from other computer based ECG systems, such as an ECG management system. The Cardiologs ECG Analysis Platform provides ECG signal processing and analysis, QRS and Ventricular Ectopic Beat detection, QRS feature extraction, interval measurement, heart rate measurement, and rhythm analysis. The Cardiologs ECG Analysis Platform is not for use in life supporting or sustaining systems or ECG monitor and Alarm devices. The product can be integrated into computerized ECG monitoring devices. In this case, the medical device manufacturer will identify the indication for use depending on the application of their device. Cardiologs ECG Analysis Platform interpretation results are not intended to be the sole means of diagnosis. It is offered to physicians and clinicians on an advisory basis only in conjunction with the physician’s knowledge of ECG patterns, patient background, clinical history, symptoms, and other diagnostic […]

K170568, FDA decision document · source

What the statement says

Pattern matches on the Indications for Use text. Each line is a fact that the text contains the words, not a finding about the device.

Adverse-event reports in MAUDE, by product code

As of , MAUDE held 898 reports filed against devices carrying product code DPS. That code is shared by every device of this type, not this device alone, and MAUDE reports are submitted by manufacturers, facilities and the public without FDA verification. The latest reports, in the reporter’s words:

25 September 2026 · Malfunction · DECGPageWriter TC S · Philips Medizin Systeme Böblingen GmbH · report 9610816-2026-102027

25 September 2026 · Malfunction · PageWriter · Philips Medical Systems · report 1218950-2026-100667

18 September 2026 · Malfunction · Q-Stress · BAXTER HEALTHCARE CORPORATION · report 3006087789-2026-00025

Baxter received a report stating that an exam was done earlier under the wrong patient information. This occurred after patient use. There was no patient injury or death reported with this event.

16 September 2026 · Malfunction · Midmark Digital ECG Plug-In Software Version 10.2.2 · Midmark Corporation · report 1523530-2026-00012

It was reported by 15 customers that they were getting a high heart rate on the ECG. The ECG did not calculate the heart rate correctly due to multiple instances of the ECG Plug-in being opened concurrently. The doctor reviewed the results and no medication was given or harm occurred. The customers were sent the firmware update as they were on the old firmware Plug-in version.

16 September 2026 · Malfunction · Cardiac Workstation · Philips Medizin Systeme Böblingen GmbH · report 9610816-2026-101917

It was reported that the heart rate reading is inaccurate. It is unknown if the device was in use on a patient. There was no report of patient or user harm.

Where this fits

This page is a record, not medical advice and not a safety rating. It copies FDA's fields and FDA's statement, and lists what the statement's text mentions. Read the labeling before relying on any of it.

More devices under product code DPS, in Cardiovascular, or cleared in 2017. The whole record is at FDA AI-enabled medical devices.

A device's authorized use is a sentence the record can be read against. What Apodicta does on a medical record is that reading: every line of a note, a claim or a report proved to its source or held, before it renders.

Show me on one of my files →

This device is authorized for a stated use. See a record read against what it must prove, on your own file.

Show me on my files